Evidence map›Paper›PMID 37505841›Full record

ArticleVeterinary sciences2023

Ki67 Index in Patnaik Grade 2/Kiupel Low-Grade Canine Cutaneous Mast Cell Tumors with Early Lymph Node Metastasis: A Descriptive Study.

Marzia Cino, Elisa Maria Gariboldi, Damiano Stefanello, Kevin Pascal Spindler, Erica Ilaria Ferraris, Emanuela Maria Morello, Luca Bertola, Lorella Maniscalco, Marina Martano

Open access · goldAbstract read
In one paragraph

Article in Veterinary sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. The Use of Sentinel Lymph Node Mapping for Canine Mast Cell Tumors.Animals : an open access journal from MDPI · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marzia CinoDepartment of Veterinary Medical Sciences, University of Parma, Strada del Taglio 10, 43126 Parma, Italy.ORCID 0000-0003-1749-1849
Elisa Maria GariboldiDepartment of Veterinary Medicine and Animal Sciences, University of Milan, Via dell' Università 1, 26900 Lodi, Italy.ORCID 0000-0002-6705-6653
Damiano StefanelloDepartment of Veterinary Medicine and Animal Sciences, University of Milan, Via dell' Università 1, 26900 Lodi, Italy.ORCID 0000-0003-2726-0366
Kevin Pascal SpindlerDepartment of Veterinary Medical Sciences, University of Parma, Strada del Taglio 10, 43126 Parma, Italy.ORCID 0000-0003-4751-9072
Erica Ilaria FerrarisDepartment of Veterinary Sciences, University of Torino, Largo Braccini 2, 10095 Grugliasco, Italy.ORCID 0000-0002-7164-0617
Emanuela Maria MorelloDepartment of Veterinary Sciences, University of Torino, Largo Braccini 2, 10095 Grugliasco, Italy.ORCID 0000-0002-9801-6646
Luca BertolaDepartment of Veterinary Medicine and Animal Sciences, University of Milan, Via dell' Università 1, 26900 Lodi, Italy.
Lorella ManiscalcoDepartment of Veterinary Sciences, University of Torino, Largo Braccini 2, 10095 Grugliasco, Italy.ORCID 0000-0001-5504-7218
Marina MartanoDepartment of Veterinary Medical Sciences, University of Parma, Strada del Taglio 10, 43126 Parma, Italy.ORCID 0000-0002-2159-0930
University of Milan · ITUniversity of Parma · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies evaluating Ki67 in canine cutaneous mast cell tumors (cMCTs) have reported its prognostic value when tumors of all histological grades are included. This study aims to evaluate whether the Ki67 index has a predictive value in a homogeneous cohort of G2/LG cMCTs with HN2 lymph nodes (LNs) and to describe the clinical outcome. The second goal was to explore the correlation between the Ki67 index and MC. The medical databases of three institutions were retrospectively searched for dogs undergoing surgical treatment for cMCT and LN extirpation, with a histological diagnosis of G2/LG with HN2 LNs. Information about histological margins, MC, Ki67 index, local recurrence, nodal relapse, distant metastasis, de novo cMCT occurrence and date and cause of death were included. A total of 39 cases were identified. None of these developed local and nodal relapse or metastatic distant disease. Median MC was 1 (0-2). Median Ki67 index was 3.5 (0.7-14.3). Ki67 and MC were not significantly correlated. At the end of the study, 32 (82%) dogs were alive, 7 (18%) dogs were dead from unrelated causes and 4 (10.2%) dogs were lost to follow-up. The median ST was not reached, and the mean was 893 days (104-2241 days). Considering the strict inclusion criteria, dogs affected by G2/LG with HN2 LNs treated with surgery alone may have a good oncologic outcome; the Ki67 index does not have prognostic impact.

Indexed as

caninecutaneous mast cell tumorHN2 lymph nodeKi67mitotic countprognostic markers

Identifiers

PMID37505841
PMCPMC10384441
OpenAlexW4383226486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.